Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 139–139 | Cite as

Gefitinib/osimertinib

Development of resistance in small cell lung cancer: case report
Case report
  • 11 Downloads

Reference

  1. Tang K, et al. Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib. Thoracic Cancer 10: 359-364, No. 2, 2019. Available from: URL: http://doi.org/10.1111/1759-7714.12927 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations